Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
978.2 USD | +1.06% | +0.51% | +11.44% |
08:40pm | Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,115 From $1,060 | MT |
May. 16 | Regeneron Pharmaceuticals Insider Sold Shares Worth $35,207,110, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 13.83B | Sales 2025 * | 14.93B | Capitalization | 104B |
---|---|---|---|---|---|
Net income 2024 * | 3.96B | Net income 2025 * | 4.42B | EV / Sales 2024 * | 6.9 x |
Net cash position 2024 * | 9.08B | Net cash position 2025 * | 14.86B | EV / Sales 2025 * | 6 x |
P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
25.3
x | Employees | 13,677 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on Regeneron Pharmaceuticals, Inc.
1 day | +1.05% | ||
1 week | +0.51% | ||
Current month | +9.90% | ||
1 month | +8.61% | ||
3 months | +3.37% | ||
6 months | +21.98% | ||
Current year | +11.44% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 88-01-07 | |
Chief Executive Officer | 71 | 88-01-07 | |
Director of Finance/CFO | 54 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christine Poon
BRD | Director/Board Member | 71 | 10-11-11 |
Chief Executive Officer | 71 | 88-01-07 | |
Michael Brown
BRD | Director/Board Member | 82 | 91-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.27% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 978.8 | +1.12% | 214 988 |
24-05-16 | 968 | -1.05% | 407,581 |
24-05-15 | 978.2 | -0.65% | 593,508 |
24-05-14 | 984.6 | +0.79% | 308,034 |
24-05-13 | 977 | +0.32% | 284,348 |
Delayed Quote Nasdaq, May 17, 2024 at 02:40 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.44% | 104B | |
+9.20% | 114B | |
-13.82% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.82% | 17.89B | |
+7.86% | 14.28B | |
+34.77% | 12.55B | |
-25.35% | 8.45B |
- Stock Market
- Equities
- REGN Stock